Merus Labs International Inc. (TSE:MSL – Get Free Report) (NASDAQ:MSLI) shares traded up 0.6% on Monday . The company traded as high as C$1.65 and last traded at C$1.65. 21,975 shares were traded during trading, a decline of 95% from the average session volume of 476,228 shares. The stock had previously closed at C$1.64.
Merus Labs International Stock Performance
The company’s 50-day simple moving average is C$1.65.
About Merus Labs International
Merus Labs International Inc is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company’s products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin.
Featured Articles
- Five stocks we like better than Merus Labs International
- Consumer Discretionary Stocks Explained
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Earnings Per Share Calculator: How to Calculate EPS
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Why Invest in 5G? How to Invest in 5G Stocks
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Merus Labs International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus Labs International and related companies with MarketBeat.com's FREE daily email newsletter.
